Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 3 |
2023 | 0 |
Search Results
5 results
Results by year
Page 1
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Cannabis Cannabinoid Res. 2022 Oct;7(5):658-669. doi: 10.1089/can.2021.0093. Epub 2021 Oct 7.
Cannabis Cannabinoid Res. 2022.
PMID: 34619044
Clinical Trial.
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.
Crippa JAS, Zuardi AW, Guimarães FS, Campos AC, de Lima Osório F, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Pacheco JC, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Pereira-Lima K, Sen S, Andraus MH, Hallak JEC; Burnout and Distress Prevention With Cannabidiol in Front-line Health Care Workers Dealing With COVID-19 (BONSAI) Trial Investigators.
Crippa JAS, et al. Among authors: pacheco jc.
JAMA Netw Open. 2021 Aug 2;4(8):e2120603. doi: 10.1001/jamanetworkopen.2021.20603.
JAMA Netw Open. 2021.
PMID: 34387679
Free PMC article.
Item in Clipboard
Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022).
Souza JDR, Pacheco JC, Rossi GN, de-Paulo BO, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA, Dos Santos RG.
Souza JDR, et al. Among authors: pacheco jc.
Pharmaceutics. 2022 Nov 25;14(12):2598. doi: 10.3390/pharmaceutics14122598.
Pharmaceutics. 2022.
PMID: 36559092
Free PMC article.
Review.
Item in Clipboard
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Souza JDS, Zuardi AW, Guimarães FS, Osório FL, Loureiro SR, Campos AC, Hallak JEC, Dos Santos RG, Machado Silveira IL, Pereira-Lima K, Pacheco JC, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Andraus MH, Crippa JAS.
Souza JDS, et al. Among authors: pacheco jc.
Front Pharmacol. 2022 Oct 3;13:856846. doi: 10.3389/fphar.2022.856846. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36263136
Free PMC article.
Item in Clipboard
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic.
Pacheco JC, Souza JDS, Hallak JEC, Osório FL, Campos AC, Guimarães FS, Zuardi AW, Crippa JAS.
Pacheco JC, et al.
J Clin Psychopharmacol. 2021 May-Jun 01;41(3):327-329. doi: 10.1097/JCP.0000000000001405.
J Clin Psychopharmacol. 2021.
PMID: 33843818
No abstract available.
Item in Clipboard
Cite
Cite